Union Bancaire Privee UBP SA Invests $280,000 in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Union Bancaire Privee UBP SA purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 3,914 shares of the company's stock, valued at approximately $280,000.

Other hedge funds have also recently made changes to their positions in the company. State Street Corp lifted its stake in shares of GE HealthCare Technologies by 7.8% in the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company's stock valued at $1,747,101,000 after acquiring an additional 1,347,114 shares during the last quarter. Geode Capital Management LLC lifted its position in GE HealthCare Technologies by 7.2% in the third quarter. Geode Capital Management LLC now owns 10,977,757 shares of the company's stock valued at $1,026,898,000 after purchasing an additional 733,819 shares during the last quarter. Van ECK Associates Corp boosted its stake in shares of GE HealthCare Technologies by 107.3% during the fourth quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company's stock valued at $378,520,000 after purchasing an additional 2,506,417 shares during the period. D1 Capital Partners L.P. bought a new position in shares of GE HealthCare Technologies in the third quarter worth approximately $268,159,000. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of GE HealthCare Technologies by 12.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,710,938 shares of the company's stock worth $254,422,000 after purchasing an additional 290,019 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

Remove Ads

GE HealthCare Technologies Stock Down 2.3 %

Shares of NASDAQ GEHC traded down $2.05 on Friday, reaching $87.35. 4,214,326 shares of the company's stock traded hands, compared to its average volume of 2,884,907. The business's 50 day simple moving average is $86.00 and its two-hundred day simple moving average is $86.07. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80. The company has a market cap of $39.94 billion, a price-to-earnings ratio of 20.17, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on GEHC. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and boosted their price objective for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a report on Friday, February 14th. Finally, Citigroup increased their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a report on Thursday, February 13th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of "Moderate Buy" and a consensus price target of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.